South Street Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.37M | Sell |
63,366
-110,635
| -64% | -$7.64M | 0.65% | 36 |
|
2025
Q1 | $12.1M | Buy |
174,001
+6,840
| +4% | +$475K | 1.98% | 23 |
|
2024
Q4 | $14.4M | Sell |
167,161
-19,370
| -10% | -$1.67M | 2.2% | 20 |
|
2024
Q3 | $22.2M | Sell |
186,531
-44,988
| -19% | -$5.36M | 3.37% | 8 |
|
2024
Q2 | $33M | Sell |
231,519
-3,209
| -1% | -$458K | 5.01% | 4 |
|
2024
Q1 | $30.1M | Sell |
234,728
-5,099
| -2% | -$655K | 4.81% | 4 |
|
2023
Q4 | $24.8M | Sell |
239,827
-943
| -0.4% | -$97.6K | 4.64% | 5 |
|
2023
Q3 | $21.9M | Buy |
240,770
+2,042
| +0.9% | +$186K | 4.4% | 4 |
|
2023
Q2 | $19.3M | Sell |
238,728
-66,478
| -22% | -$5.38M | 3.83% | 6 |
|
2023
Q1 | $24.3M | Buy |
305,206
+188
| +0.1% | +$15K | 4.98% | 3 |
|
2022
Q4 | $20.6M | Sell |
305,018
-7,716
| -2% | -$522K | 4.56% | 2 |
|
2022
Q3 | $15.6M | Sell |
312,734
-4,710
| -1% | -$235K | 3.84% | 6 |
|
2022
Q2 | $17.7M | Buy |
317,444
+132,610
| +72% | +$7.39M | 4.03% | 2 |
|
2022
Q1 | $10.3M | Buy |
+184,834
| New | +$10.3M | 1.94% | 26 |
|